Spec. MD. Gyulnaz Durmushalı Emın

Education and Expertise

• 2008-2014 Istanbul University Cerrahpaşa Faculty of Medicine, Dr.
• 2015-2019 Istanbul University Cerrahpaşa Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Specialist.
Dr.

Experience

• 2019-2022 Private Fizyodem Medical Center
• 2022-2022 Private Ornöram Physical Therapy and Rehabilitation Center
• 2022-2025 Yeni Yüzyıl University Private Gaziosmanpaşa Hospital
• 2025 - Present İstinye University Gaziosmanpaşa Hospital

Foreign Language

• English

Courses and Certificates

• 2021 Ozone Therapy - Ministry of Health Getat Trainings Ozone Therapy Training
• 2024 Botulinum Toxin Application Course with Case Studies
• 2022 Intravenous Vitamin and Amino Acid Use Training
• 2019 PRP (Platelet Rich Plasma) Course
• 2018 Musculoskeletal System Ultrasound - Basic Training Course
• 2018 Kinesiological Taping Course
• 2018 Electromyography (ENMG) Course with Case Studies
• 2018 Traumatic Hand Rehabilitation Course
• 2018 Botulinum Toxin Application Course
• 2018 Exercise Prescription Course for Spinal Pains
• 2018 Cardiac Rehabilitation Course VIII. Winter School
• 2018 Osteoporosis and Metabolic Bone Diseases Course

Professional Memberships

• Turkish Physical Medicine and Rehabilitation Association
• Turkish Rheumatism Research and Combat Association
• Istanbul Medical Chamber

• 1. Quality Of Life In Sarcopenia Measured With The Sarqol Questionnaire: A Meta-Analysis Of Individual Patient Data. Beaudart C, Tilquin N, Abramowicz P, Baptista F, Peng DJ, de Souza Orlandi F, Drey M, Dzhus M, Fábrega-Cuadros R, Fernandez-Garrido J, Laurindo LF, Gasparik AI, Geerinck A, Emin G, Iacob S, Kilaitė J, Kumar P, Lee SC, Lou VWQ, Mahmoodi M, Matijevic R, Matveeva MV, Merle B, Montero-Errasquín B, Bhattoa HP, Safonova Y, Şimşek H, Topinkova E, Tsekoura M, Erdoğan T, Yoo JI, Yu R, Hiligsmann M, Reginster JY, Bruyère O. Maturitas. 2024 Feb;180:107902. doi: 10.1016/j.maturitas.2023.107902. Epub 2023 Dec 15. PMID: 3814246
• 2. Multinational and Multicenter Phase III Drug Trial (Associate Investigator), 2018. A randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of IGN-ES001 in patients with chronic widespread pain, with or without fibromyalgia. exploratory study
• 3. Evaluation of Sarcopenia by SarQOL Questionnaire in Postmenopausal Osteoporotic Patients (World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Barcelona 2020 - Poster Presentation)
• 4. A Case of Sacral Insufficiency Fracture Mimicking Spondylarthropathy Developed Due to Osteomalacia Associated with Celiac Disease (International Turkish Rheumatology Congress 2019 - Poster Presentation)
• 5. Development of Syringomyelia in a Patient with Ankylosing Spondylitis and its Response to Etanercept Treatment (Rader Winter Workshop 2018 - Oral Presentation)
• 6. Late Development of RS3PE Syndrome and Effectiveness of Steroid Treatment in a Female Case with Periodic Ankylosing Spondylitis (International Turkish Rheumatology Congress 2018 - Poster Presentation)
• 7. Head and Neck Lymphedema Developing After Supraglottic Laryngectomy: Case Report (Traditional 15th FTR Uludağ Symposium 2018 - Poster Presentation)
• 8. Malignancy Case Causing Acute Non-Traumatic Burst Type Vertebral Fracture (FTR Course Days Congress 2018 - Poster Presentation)